Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention CDC Home Search CDC CDC Health Topics A-Z    
Office of Genomics and Disease Prevention  
Office of Genomics and Disease Prevention

Nature vs. Nurture: A Public Health Perspective

spacer

Nature vs. Nurture: A Public Health Perspective


Researching the weekly update, OGDP finds scientific literature that reports on discoveries of genetic variants, related disease outcomes, and the complex social, legal, and ethical issues surrounding genetic discoveries. A Public Health Perspective focuses on a single topic and provides you with information relevant to public health practice.

This week we are examining the public health perspective of pharmacogenomics , a burgeoning field that promises to revolutionize medicine by deciphering the genetic basis of variable drug response in individual people. (February 2001)

"For clinical medicine, pharmacogenomics holds promise of individualized drug treatment. For public health, the promise is targeted disease prevention."
The Office of Genomics and Disease Prevention


top
chromosome button
The Public Health Perspective
 
   
chromosome button
Journal Articles
 
   
chromosome button

News Stories

 
   
chromosome button Business News
 
   
chromosome button
Slide
  Pharmacogenomics, "Drugs by Design?"
preview now
  -  PowerPoint version   -  download now
   
chromosome button
Reader's Forum
 

The Reader's Forum is an opportunity to share your thoughts about Pharmacogenomics:  A Public Health Perspective. Please participate by sending us your comments on this or any in our series of Public Health Perspectives.

Reader's comments

bottom
bottom
Last Updated August 12, 2004